Ambition at Sanger

Mike Stratton is the new director of the Wellcome Trust Sanger Institute, according to the Wellcome Trust's blog. Stratton, who studies cancer genetics, has been at Sanger since 2000 and became deputy director in 2007. "I aim to build ambitiously on the Institute's current leadership in large-scale analysis of genomes and experimental studies in model organisms to develop cellular systems that will explore human biology and to provide transformative insights into how diseases develop," Stratton says in a statement. He succeeds Allan Bradley, who left the institute in March.